Apoteca Pharma Private Limited
About Apoteca Pharma Private Limited
Data last updated:
Apoteca Pharma Private Limited is a private limited company based in Indore, Madhya Pradesh, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 15 April 2022.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U51909MP2022PTC060416.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Ajay Chaturvedi and Chitra Manish Sharma.
Its last annual general meeting (AGM) was held on 31 December 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 81 Rajmahal Colony, Indore, Madhya Pradesh, India – 452007.
As per the financials filed for FY 2024, the company reported a revenue of ₹2.09 Cr, a decline of 29% compared to the previous year. For the same year it recorded a net loss of ₹9.57 Lakh (net margin -4.6%) and EBITDA of -₹8.34 Lakh (EBITDA margin -4%).
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address81 Rajmahal Colony, Indore, Madhya Pradesh, India – 452007
- IndustryTrading, Specialty, Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Apoteca Pharma Private Limited
The main business activity of Apoteca Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Apoteca Pharma Private Limited FY 2024 filings available
Apoteca Pharma Private Limited reported revenue of ₹2.09 Cr (down 29% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Apoteca Pharma Private Limited
Revenue fell 29% in the latest year. EBITDA fell 373% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Apoteca Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | •••• |
| Other Income | •••• | •••• |
| Total Revenue | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• |
| Employee Benefit Expense | •••• | •••• |
| Finance Costs | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• |
| Other Expenses | •••• | •••• |
| Total Expenses | •••• | •••• |
| EBITDA | -₹8.34 Lakh | •••• |
| Profit Before Tax | •••• | •••• |
| Tax Expense | •••• | •••• |
| Net Profit (PAT) | -₹9.57 Lakh | •••• |
| Balance Sheet | ||
| Share Capital | •••• | •••• |
| Reserves and Surplus | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• |
| Long-term Borrowings | •••• | •••• |
| Short-term Borrowings | •••• | •••• |
| Trade Payables | •••• | •••• |
| Total Liabilities | •••• | •••• |
| Fixed Assets | •••• | •••• |
| Investments | •••• | •••• |
| Inventories | •••• | •••• |
| Trade Receivables | •••• | •••• |
| Cash and Bank Balance | •••• | •••• |
| Total Assets | •••• | •••• |
Financial Ratios of Apoteca Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -4% | •••• |
| Net Profit Margin | -4.6% | •••• |
| Return on Equity (ROE) | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• |
| Liquidity and Debt | ||
| Current Ratio | •••• | •••• |
| Quick Ratio | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• |
| Efficiency and Growth | ||
| Asset Turnover | •••• | •••• |
| Receivable Days | •••• | •••• |
| Payable Days | •••• | •••• |
| Inventory Days | •••• | •••• |
| Revenue Growth | •••• | •••• |
| Net Profit Growth | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Apoteca Pharma are in the company report.
Financial statements from FY 2023
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Apoteca Pharma Private Limited
Apoteca Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mihir Synthetics Private Limited | ₹2.1 Cr (FY 2025) | •••• | •••• | 39.0% | •••• | Mumbai, Maharashtra, India |
| Pharma Corner Private Limited | ₹2.1 Cr (FY 2025) | •••• | •••• | 7.0% | •••• | Hathras, Uttar Pradesh, India |
| Gemshi Pharmaceuticals Private Limited | ₹2.1 Cr (FY 2025) | •••• | •••• | 143.0% | •••• | Ulhasnagar, Maharashtra, India |
| Lotus Medicare Services Private Limited | ₹2.1 Cr (FY 2017) | •••• | •••• | 4.0% | •••• | Bangalore, Karnataka, India |
| Maxis Healthcare (I) Private Limited | ₹2.09 Cr (FY 2024) | •••• | •••• | 10.0% | •••• | Gokal Puri, Delhi, India |
| Apoteca Pharma Private Limited this company | ₹2.09 Cr (FY 2024) | •••• | •••• | -29.0% | •••• | Indore, Madhya Pradesh, India |
| Stockshift India Private Limited | ₹2.09 Cr (FY 2023) | •••• | •••• | 0.0% | •••• | Barshi, Maharashtra, India |
| Veonline Healthcare & Retail Services Private Limited | ₹2.09 Cr (FY 2025) | •••• | •••• | -14.0% | •••• | Navi Mumbai, Maharashtra, India |
| Prosthetic Asia Private Limited | ₹2.09 Cr (FY 2025) | •••• | •••• | 51.0% | •••• | New Delhi, Delhi, India |
| Deepodaya Pharmaceuticals Private Limited | ₹2.08 Cr (FY 2025) | •••• | •••• | -51.0% | •••• | Lucknow, Uttar Pradesh, India |
| Karas Health Care Private Limited | ₹2.08 Cr (FY 2025) | •••• | •••• | 61.0% | •••• | Paravur, Kerala, India |
Peers are the five companies nearest above and the five nearest below Apoteca Pharma by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Apoteca Pharma Private Limited
Apoteca Pharma has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ajay Chaturvedi | Director | 15 Apr 2022 | 4 Years 5 Months | Current |
| Chitra Manish Sharma | Director | 15 Apr 2022 | 4 Years 5 Months | Current |
| Suresh Kumar | Additional Director | 05 Dec 2024 | 1 Years 10 Months | Current |
Charges & Borrowings of Apoteca Pharma Private Limited
Apoteca Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Apoteca Pharma Private Limited
Employment history and EPFO contributions of people linked to Apoteca Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Apoteca Pharma Private Limited
Apoteca Pharma Private Limited has 3 board changes on record since 2022: 3 appointments. The latest: Suresh Kumar was appointed as Additional Director on 05 Dec 2024.
Credit Ratings, Litigation & Regulatory Alerts for Apoteca Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Apoteca Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Apoteca Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Apoteca Pharma Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Apoteca Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Apoteca Pharma Private Limited
Apoteca Pharma is an active private limited company based in Indore, Madhya Pradesh, India. The company works in specialty, within the trading industry. It was incorporated on 15 April 2022 (4+ years old) and is registered under CIN U51909MP2022PTC060416.
Apoteca Pharma reported revenue of ₹2.09 Cr for FY 2024 (down 29% YoY).
Apoteca Pharma has 3 current directors:
- Ajay Chaturvedi - Director
- Chitra Manish Sharma - Director
- Suresh Kumar - Additional Director
Apoteca Pharma reported a net loss of ₹9.57 Lakh (net margin -4.6%) and EBITDA of -₹8.34 Lakh (EBITDA margin -4%) for FY 2024, as per its filed financial statements.
The CIN (Corporate Identification Number) of Apoteca Pharma is U51909MP2022PTC060416. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Apoteca Pharma was incorporated on 15 April 2022, making it 4+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Apoteca Pharma by revenue are Mihir Synthetics Private Limited, Pharma Corner Private Limited, Gemshi Pharmaceuticals Private Limited, Lotus Medicare Services Private Limited, Maxis Healthcare (I) Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Suresh Kumar was appointed as Additional Director on 05 Dec 2024. Ajay Chaturvedi was appointed as Director on 15 Apr 2022. Chitra Manish Sharma was appointed as Director on 15 Apr 2022.
The registered office of Apoteca Pharma is at 81 Rajmahal Colony, Indore, Madhya Pradesh, India – 452007.
Apoteca Pharma has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1 Lakh.
Apoteca Pharma operates in the trading industry, in the specialty segment.